WallachBeth Capital Announce Closing Of 60 Degrees Pharmaceuticals IPO At $5.30 Per Unit
- 60 Degrees Pharmaceuticals, Inc. successfully raised $7.5 million in its IPO, which could positively impact its stock price. The company offered 1,415,095 units at a price of $5.30 per unit, providing a significant infusion of capital for future growth.
- None.
WallachBeth Capital, LLC is the Sole Bookrunner for the Offering.
A registration statement on Form S-1, as amended (File No. 333-269483), relating to these securities was filed with the SEC and was declared effective on July 11, 2023. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About WallachBeth Capital LLC.
WallachBeth Capital offers a robust range of capital markets and investment banking services to the healthcare community. The firm's experience includes initial public offerings, follow-on issues, PIPE offerings, and private transactions. The firm's website is located at www.wallachbeth.com.
This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding the anticipated use of proceeds from the Company's offering of its units. Forward-looking statements can be identified by words such as "believes," "expects," "estimates," "intends," "may," "plans," "will" and similar expressions, or the negative of these words. Such forward-looking statements are based on facts and conditions as they exist at the time such statements are made and predictions as to future facts and conditions. Readers of this press release are cautioned not to place undue reliance on any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statement relating to matters discussed in this press release, except as may be required by applicable securities laws.
View original content to download multimedia:https://www.prnewswire.com/news-releases/wallachbeth-capital-announce-closing-of-60-degrees-pharmaceuticals-ipo-at-5-30-per-unit-301877686.html
SOURCE WallachBeth Capital LLC
FAQ
What is the IPO price of 60 Degrees Pharmaceuticals, Inc.?
How much capital did 60 Degrees Pharmaceuticals, Inc. raise in its IPO?